Scancell Share Discussion Threads

[miavoce] 15/12/2017 07:41

Thanks Inanaco

[chelsea35] 15/12/2017 04:09

Goyathley, the pick of the posts today IMO.

Maybe just sometimes we can look at the news we got today and just say it is very good, we have a long way to go, so many indications identified, much news to come and that all important "external validation". Who knows what that alone might open for us, i am sure the BOD know exactly what.

I have been saying for quite a while we have a seller, active yesterday again and with 14.50 paid 13 times very sure will offload more today. Will be good to see whoever it is cleared very soon.

I feel this RNS will build in momentum, one thing i know for sure is that i added 35k shares in the hope of such news at 11.8125 and 11.85, and feel a lot more confident today than i have felt for some considerable time. I am sure i am not the only one.

GL All here, i am sure i had a tenner bet with TF that SCIB2 would provide that validation. If you"re reading this TF please put it into a charity in Thailand for cancer care. Have a good day.

[inanaco] 14/12/2017 23:52

Miavoice, its identical .. no adjustment

[miavoce] 14/12/2017 22:04

Thanks inanco. Does the formulation not need to be adjusted for other indications or is it identical for all cancers that over express the same protein ?

[inanaco] 14/12/2017 21:47

miavoice the other indications for scib2 won't need a phase 1 trial dose escalation phase, if efficacy is seen in the phase 1 part of the NSCLC they may elect to expand before they have the phase 2 results into the other indications.

[miavoce] 14/12/2017 19:58

Reading the announcement again it looks as though there is an intention for CRUK to undertake a series of Phase 1/2 trials on a range of solid tumour cancers (assuming that the NSCLC trial is successful) - makes this look like an ever better deal than it first appeared.

I guess if these Phase 1/2's are successful this would then provide the basis for subsequent commercial partnerships (I can see why pharma's would not be rushing to partner on a product that had not even been through phase 1/2).

[miavoce] 14/12/2017 19:53

CRUK have some very large companies on their CDP Programme:-

[wigwammer] 14/12/2017 17:47

+14%. Guess it was good news today after all :)

[bermudashorts] 14/12/2017 12:02

Waterloo,

Yes understand that the market (especially short term traders) like a good old fashioned pharma deal, was just commenting on your point re. loss of control.

Article from labiotech

"The success rate of this model is not different from that of a pharmaceutical company. Which is remarkable given that CRUK is a charity fully funded by donations, without government subsidies. A great example for emerging institutions bidding for the non-profit model in biotech."

hxxps://labiotech.eu/scancell-cruk-cancer-vaccine/

[the real lozan] 14/12/2017 11:54

Things that go un-noticed by many - but not ALL =
Does no-one find the 'JUMP' in S P the other day... for NO apparent reason ... not even 'a little bit suspect' ???
.
Nothing wrong with the news today
BUT
ANY news WAS going to be 'played-up' by the punk group Nappy and the trHYPERS....
to the point that all those who were predicting "DEFINATE multi-bags / We are SURE to see S P LIFT-OFF today" ETC, ETC =
Are, in REALITY, left DISAPPOINTED that their LOSSES are to remain for some time yet.
10% as of... is not REALLY "Multi-bags" is it ???
.
NO DOUBT, Nappy 'n' co, will DEMAND...... IT IS { or WILL be SOON, or ... at least, in Nappy 5 year terms .... IMMINENT { so BUY, BUY, BUY... so HE CAN SELL / recover HIS LOSSES}
.
LONG way to go yet.

[agema] 14/12/2017 10:50

Waterloo01

I agree m8. No disrespect to anyone here. But you generally deal with charities, only after you have exhausted trying to get a deal with a big pharma company. Which is probably why the share price is now contracting.

[waterloo01] 14/12/2017 10:39

Bermuda, I'm very possibly wrong. I don't follow SCLP that closely but generally much prefer to see pharma putting some ££ behind it.

[bermudashorts] 14/12/2017 10:09

Waterloo,

They haven't licensed the IP to CRUK so in that sense retain full ownership and control of the drug. The question then remains as to whether or not you believe CRUK have the knowledge and ability to carry out a clinical trial.

We all know the situation re. cancer vaccines and the fact that they have found a non-dilutive way of taking SCIB2 into the clinic can't possibly be described as anything other than great news.

[agema] 14/12/2017 09:57

If you think that the worldwide Pharma industry not wanting to buy or partner with Scancell on its product is a stupid point to make.

Then I suggest that it is you who are the stupid and deluded one.

Have a good day.

[wigwammer] 14/12/2017 09:49

The pharma guys are intelligent, but the research staff at CRUK are not?Your point is so stupid it doesn't warrant a response.

[agema] 14/12/2017 09:41

Lol. The intelligent pharma guys were not interested. That’s an obvious not intelligent point.

Charities give money away. Pharm companies need to make it. The makers turned it down, the throwers threw it. Fact.

[miavoce] 14/12/2017 09:41

It seems clear that Scancell knew well before the AGM that the SCIB2 trial would take place in the UK (and therefore must have been in late stage discussions with CRUK), so the funds that RG hinted at must be coming from another source.I suspect that it will be the granting of the moditope patent that will unlock a deal that brings cash with it.

[wigwammer] 14/12/2017 09:38

A highly prestigious cancer charity "takes up the slack" in full knowledge they are throwing money away.It's an intelligent point ;)

[agema] 14/12/2017 09:31

Not Great news when the Pharma industry and its experts turn down the chance to partner and its left to a charity to take up the slack.

Scancell will not greatly and lastingly gain in share price until the trials are started and hard data comes through.So the coin will be in the air for well over a year at least.

[wigwammer] 14/12/2017 09:30

"Its welcome news.."Well done.

[waterloo01] 14/12/2017 09:28

CRUK are an excellent organisation and partner however I'm not sure this is quite the news folk have been hoping (ie pharma partner with ££ attached).

Haven't they just effectively lost control of the drug. CRUK might progress faster than SCLP could have done (not hard) but SCLP are bystanders going forward.

I know you have some decent folk here as holders and I might be very wrong and the share will fly going forward. (I shan't share my views on VAL which I've always considered to be a basket case and questionable trial results recently published).

For transparency I sold my very small holding this AM. Happy to book a profit.

[j777j] 14/12/2017 09:24

This will make other potential partners sit up and realise they might miss out to another player.Plenty more newsflow in the pipeline.